Current Evidence and Future Directions of Omega-3 Supplementation and Cardiovascular Disease Risk
- PMID: 38352637
- PMCID: PMC10861298
- DOI: 10.1055/s-0043-1777258
Current Evidence and Future Directions of Omega-3 Supplementation and Cardiovascular Disease Risk
Abstract
Omega-3 supplementation has a controversial role in the secondary prevention of cardiovascular diseases. Despite large clinical trials published over the years, the evidence of omega-3 in preventing cardiovascular diseases, especially coronary heart disease, is still inconclusive. However, recent clinical trials using higher dose of omega-3 or highly purified esters of omega-3 shows promising result, with reduction in cardiovascular death and incidence of cardiovascular disease. This review aims to summarize the possible mechanism of omega-3 in preventing cardiovascular disease and future directions of research regarding the benefit of omega-3 in cardiovascular disease.
Keywords: atherosclerosis; cardiovascular disease; eicosapentaenoic acid; fatty acid; omega-3; prevention.
International College of Angiology. This article is published by Thieme.
Conflict of interest statement
Conflict of Interest None declared.
Figures
References
-
- Kromhout D, Bosschieter E B, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312(19):1205–1209. - PubMed
-
- Arnett D K, Blumenthal R S, Albert M A et al.2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e563–e595. - PMC - PubMed
-
- ESC Scientific Document Group . Mach F, Baigent C, Catapano A L et al.2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(01):111–188. - PubMed
-
- OMEGA Study Group . Rauch B, Schiele R, Schneider S et al.OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation. 2010;122(21):2152–2159. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
